Resmed Inc ADR (RSMD.F)
ResMed Inc. ADR is a depositary receipt representing the company’s common stock on OTC Markets under the symbol RSMD.F. The underlying issuer develops digital health and cloud-connected medical devices for use in the United States and internationally. Its operations are organized into two segments: Sleep and Breathing Health, and Residential Care Software. The company’s sleep and breathing health portfolio includes diagnostic and therapy-related products such as ApneaLink Air, NightOwl, and EasyCare Tx for sleep apnea evaluation and sleep lab workflows. It also provides connected platforms and applications, including AirView for remote device monitoring and settings management and myAir for patient support and therapy engagement. In addition, ResMed offers software solutions through Brightree, HEALTHCAREfirst, MatrixCare, and MEDIFOX DAN for home medical equipment, pharmacy, home health, hospice, skilled nursing, senior living, and residential care providers. ResMed was founded in 1989 and is headquartered in San Diego, California.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-RSMD.F
|
$24.44
|
1.5% Upside
|
Fair
|
Not available
|
Not available
|
Great
|
0.0%
|
January 28, 2027
|
21.2x
|
5.7x
|
5.9x
|
33.692 B
|
33.317 B
|
1.8%
|
99.4%
|
14.1
|
22.4%
|
101.0%
|